Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice

J Immunol. 2010 Apr 15;184(8):4196-204. doi: 10.4049/jimmunol.0903931. Epub 2010 Mar 10.

Abstract

There is compelling evidence that self-reactive CD8(+) T cells are a major factor in development and progression of type 1 diabetes in animals and humans. Hence, great effort has been expended to define the specificity of autoimmune CD8(+) T cells and to alter their responses. Much work has focused on tolerization of T cells using proteins or peptides. A weakness in this approach is that residual autoreactive T cells may be activated and exacerbate disease. In this report, we use a novel approach, toxin-coupled MHC class I tetramers. Used for some time to identify Ag-specific cells, in this study, we use that same property to delete the Ag-specific cells. We show that saporin-coupled tetramers can delete islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)-reactive T cells in vitro and in vivo. Sequence analysis of TCRbeta-chains of IGRP(+) cells reveals the repertoire complexity in the islets is markedly decreased as NOD mice age and significantly altered in toxic tetramer-treated NOD mice. Further tetramer(+) T cells in the islets are almost completely deleted, and, surprisingly, loss of tetramer(+) T cells in the islets is long lasting. Finally, we show deletion at 8 wk of age of IGRP(+) CD8(+) T cells, but not dystophia myotonica kinase- or insulin B-reactive cells, significantly delays diabetes in NOD mice.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantigens / immunology
  • Autoantigens / metabolism
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / pathology*
  • Cell Death / immunology
  • Cell Movement / immunology
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / pathology
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Disease Progression
  • Epitopes, T-Lymphocyte / immunology
  • Female
  • Glucose-6-Phosphatase / administration & dosage
  • Glucose-6-Phosphatase / biosynthesis
  • Glucose-6-Phosphatase / immunology
  • H-2 Antigens / administration & dosage*
  • H-2 Antigens / toxicity
  • Histocompatibility Antigen H-2D
  • Immunotoxins / administration & dosage*
  • Immunotoxins / toxicity
  • Islets of Langerhans / immunology
  • Islets of Langerhans / pathology
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Mice, Transgenic
  • Molecular Mimicry / immunology
  • Proteins / administration & dosage
  • Proteins / immunology
  • Receptors, Antigen, T-Cell, alpha-beta / biosynthesis
  • Receptors, Antigen, T-Cell, alpha-beta / genetics
  • Ribosome Inactivating Proteins, Type 1 / administration & dosage
  • Ribosome Inactivating Proteins, Type 1 / toxicity*
  • Saporins
  • beta 2-Microglobulin / administration & dosage*
  • beta 2-Microglobulin / toxicity

Substances

  • Autoantigens
  • Epitopes, T-Lymphocyte
  • H-2 Antigens
  • H-2K(K) antigen
  • Histocompatibility Antigen H-2D
  • Immunotoxins
  • Proteins
  • Receptors, Antigen, T-Cell, alpha-beta
  • Ribosome Inactivating Proteins, Type 1
  • beta 2-Microglobulin
  • Glucose-6-Phosphatase
  • G6pc2 protein, mouse
  • Saporins